Literature DB >> 2893920

Cohort study of intestinal infection with campylobacter in Mexican children.

J J Calva1, G M Ruiz-Palacios, A B Lopez-Vidal, A Ramos, R Bojalil.   

Abstract

A cohort of 179 children under 5 years of age from a low-income urban community was followed up for a year to determine the incidence of symptom-producing and of diarrhoea-free campylobacter intestinal infections, and thus their illness-to-infection ratio. 66% of all children had at least one campylobacter infection, one-third of these being associated with diarrhoea. The annual incidence of all campylobacter infections was 2.1 episodes per child. The incidence was inversely related to age (r = -0.78 p less than 0.02). The illness-to-infection ratio, which in infants younger than 6 months was 1:2, was negatively associated with age (r = -0.7, p less than 0.02). Only symptom-producing infections occurring early in life seemed to protect against subsequent infections.

Entities:  

Mesh:

Year:  1988        PMID: 2893920     DOI: 10.1016/s0140-6736(88)91297-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

1.  New World monkey Aotus nancymae as a model for Campylobacter jejuni infection and immunity.

Authors:  Franca R Jones; Shahida Baqar; Alfonso Gozalo; Gladys Nunez; Nereyda Espinoza; Sharina M Reyes; Milagros Salazar; Rina Meza; Chad K Porter; Stephen E Walz
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Detection of Campylobacter in stool and determination of significance by culture, enzyme immunoassay, and PCR in developing countries.

Authors:  James A Platts-Mills; Jie Liu; Jean Gratz; Esto Mduma; Caroline Amour; Ndealilia Swai; Mami Taniuchi; Sharmin Begum; Pablo Peñataro Yori; Drake H Tilley; Gwenyth Lee; Zeli Shen; Mark T Whary; James G Fox; Monica McGrath; Margaret Kosek; Rashidul Haque; Eric R Houpt
Journal:  J Clin Microbiol       Date:  2014-01-22       Impact factor: 5.948

Review 3.  Update on the burden of Campylobacter in developing countries.

Authors:  James A Platts-Mills; Margaret Kosek
Journal:  Curr Opin Infect Dis       Date:  2014-10       Impact factor: 4.915

4.  Isolation, characterization, and host-cell-binding properties of a cytotoxin from Campylobacter jejuni.

Authors:  S Mahajan; F G Rodgers
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

5.  Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes.

Authors:  E Sjögren; G Ruiz-Palacios; B Kaijser
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

6.  Campylobacter jejuni and Campylobacter coli diarrhoea in rural and urban populations in Yugoslavia.

Authors:  T Popović-Uroić
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

7.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 8.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

9.  Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype.

Authors:  L S Mansfield; J S Patterson; B R Fierro; A J Murphy; V A Rathinam; J J Kopper; N I Barbu; T J Onifade; J A Bell
Journal:  Microb Pathog       Date:  2008-06-11       Impact factor: 3.738

10.  Molecular characterization of Campylobacter jejuni clones: a basis for epidemiologic investigation.

Authors:  Kate E Dingle; Frances M Colles; Roisin Ure; Jaap A Wagenaar; Birgitta Duim; Frederick J Bolton; Andrew J Fox; David R A Wareing; Martin C J Maiden
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.